Skip to main navigation
SEARCH
MEDIA
CAREERS
CONTACT
Our Company
Our Story
Our Leadership
Our Board of Directors
Our Partners
Locations
Contact
Our Pipeline
Clinical Resources
R&D Pipeline
Bempegaldesleukin (NKTR-214)
Dapirolizumab Pegol (Anti-CD40L)
NKTR-358
NKTR-262
NKTR-255
Clinical Trials
Expanded Access
Investigator Supported Trials
Our Medicines
U.S. Medicines Marketed by Our Partners
EU Medicines Marketed by Our Partners
Investigational Medicines
Our Science
Research Platform
Scientific Posters, Presentations and Publications
Scientific & Medical Events
Investors
Investor Relations
About Us
Press Releases
Investor Events
Stock Information
Historic Stock Lookup
Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Contact IR
Email Alerts
Media
Media Room
Video Gallery
Image Gallery
Careers
Overview
Life at Nektar
Search Jobs
Benefits at Nektar
Benefits at San Francisco, California
Benefits at Huntsville, Alabama
Benefits at Hyderabad, India
Information for Recruiters
Unsubscribe from all Nektar Therapeutics email alerts
Email Address
Leave this field blank
Investor Relations
About Us
Press Releases
Investor Events
Stock Information
Historic Stock Lookup
Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Contact IR
Email Alerts